| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8605782 | Journal of Pain and Symptom Management | 2018 | 28 Pages |
Abstract
The BQII-G12 showed excellent psychometric properties in the preliminary testing, providing a new option for practice and research. Patient-related barriers to cancer pain management are crucial for adequate pain treatment. The new valid and reliable short BQII-G12 supports clinical practice and research by substantially reducing patient burden and resources needed to measure these barriers.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Antje PhD, Patrick PhD,